Skip to main content

Featured

Wall Street Futures Tick Higher as 2026 Trading Begins

U.S. stock futures moved higher early Friday, signaling a confident start to the first trading session of 2026. The gains follow a strong multi‑year run for equities and come as investors look ahead to a new year of economic and corporate developments. Dow Jones Industrial Average futures edged up, S&P 500 futures posted a modest rise, and Nasdaq futures led the early advance with a stronger uptick. The move reflects continued enthusiasm for technology and growth‑oriented sectors, which helped drive markets through much of the previous year. Despite bouts of volatility in late 2025, major indexes closed the year with solid performance, supported by resilient consumer spending, easing inflation pressures, and expectations of a more accommodative monetary environment. As 2026 begins, traders are watching several themes: the timing and pace of potential interest‑rate cuts, the durability of tech‑sector leadership, and whether gains will broaden across more industries. Early future...

article

New Cystic Fibrosis Drug Offers Hope, but Comes with a High Price

A new drug for cystic fibrosis, Trikafta, is providing significant hope for patients suffering from the genetic disorder. Trikafta has been shown to reduce hospital visits and improve overall lung function, offering patients a better quality of life. For those living with cystic fibrosis, which affects the respiratory and digestive systems, this advancement is nothing short of a breakthrough.

However, the cost of Trikafta is a major concern. Priced at around $300,000 per year, the drug is prohibitively expensive for many patients and their families. While some health programs and insurance plans may cover the cost, access to this life-changing medication remains a challenge.

As the debate over drug pricing and healthcare accessibility continues, the medical community and patient advocacy groups are calling for measures to ensure that Trikafta is available to all who need it, regardless of their financial situation.


Comments